COMPARATIVE-STUDY OF THE IMMUNOGENICITY AND REACTOGENICITY OF NEW SOVIET VACCINES AND COMMERCIAL VACCINE FOR THE PROPHYLAXIS OF JAPANESE ENCEPHALITIS

被引：0
|
作者：
SUMAROKOV, AA [1 ]
GRACHEV, VP [1 ]
KHARAZIAN, EG [1 ]
SHKOLNIK, RY [1 ]
VOROBYEVA, MS [1 ]
GAGARINA, AV [1 ]
LAKINA, VI [1 ]
ELBERT, LB [1 ]
PERVIKOV, YV [1 ]
BORSUK, ZA [1 ]
KARASEVA, PS [1 ]
LEV, MI [1 ]
KUZNETSOV, VG [1 ]
OSTAPENKO, VD [1 ]
LOSKUTOV, AN [1 ]
GREBENSHCHIKOV, LA [1 ]
GAMBAROV, GM [1 ]
机构：
[1] ACAD MED SCI USSR,INST POLIOMYELITIS & VIRAL ENCEPHALITIS,MOSCOW,USSR
来源：
ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII | 1983年 / 09期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：74 / 79
页数：6
相关论文
共 50 条
  • [41] A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea
    Kim, Dong Soo
    Houillon, Guy
    Jang, Gwang Cheon
    Cha, Sung-Ho
    Choi, Soo-Han
    Lee, Jin
    Kim, Hwang Min
    Kim, Ji Hong
    Kang, Jin Han
    Kim, Jong-Hyun
    Kim, Ki Hwan
    Kim, Hee Soo
    Bang, Joon
    Naimi, Zulaikha
    Bosch-Castells, Valerie
    Boaz, Mark
    Bouckenooghe, Alain
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (09) : 2656 - 2663
  • [42] Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: A single-arm, single-center study
    Thiem Dinh Vu
    Quang Dang Nguyen
    Huong Thi Ai Tran
    Bosch-Castells, Valerie
    Zocchetti, Celine
    Houillon, Guy
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 66 : 137 - 142
  • [43] Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study
    Cramer, Jakob P.
    Dubischar, Katrin
    Eder, Susanne
    Burchard, Gerd D.
    Jelinek, Tomas
    Jilma, Bernd
    Kollaritsch, Herwig
    Reisinger, Emil
    Westritschnig, Kerstin
    VACCINE, 2016, 34 (38) : 4579 - 4585
  • [44] Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials
    Torresi, Joseph
    McCarthy, Karen
    Feroldi, Emmanuel
    Meric, Claude
    VACCINE, 2010, 28 (50) : 7993 - 8000
  • [45] COMPARATIVE-STUDY OF SMALLPOX VACCINES FROM B-51, EM-63, AND L-IVP STRAINS UNDER CONDITIONS OF CONTROLLED EPIDEMIOLOGICAL TRIAL .2. CHARACTERISTICS OF SMALLPOX VACCINE IMMUNOGENICITY
    KHLYABICH, GN
    SUMAROKOV, AA
    KARINSKAYA, GA
    SHKOLNIK, RY
    YAROSLAVSKAYA, NV
    MANENKOVA, GM
    POTACHEV, AF
    EPIFANOVA, KI
    ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1978, (09): : 37 - 42
  • [46] Primary Immunization of Infants and Toddlers in Thailand with Japanese Encephalitis Chimeric Virus Vaccine in Comparison with SA14-14-2 A Randomized Study of Immunogenicity and Safety
    Feroldi, Emmanuel
    Pancharoen, Chitsanu
    Kosalaraksa, Pope
    Chokephaibulkit, Kulkanya
    Boaz, Mark
    Meric, Claude
    Hutagalung, Yanee
    Bouckenooghe, Alain
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (06) : 643 - 649
  • [47] Safety and immunogenicity of rabies vaccine as 4-dose Essen Intramuscular regimen for post exposure prophylaxis: A non-randomized, comparative controlled study
    Haradanahalli, Ravish S.
    Banerjee, Rupsa
    Kalappa, Mysore Sudarshan
    Narayana, Ashwath
    Annadani, Rachana R.
    Bilagumba, Gangaboraiah
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (08) : 2554 - 2559
  • [48] Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine A Phase IV Study in Thai Children
    Sricharoenchai, Sirintip
    Lapphra, Keswadee
    Chuenkitmongkol, Sunate
    Phongsamart, Wanatpreeya
    Bouckenooghe, Alain
    Wittawatmongkol, Orasri
    Rungmaitree, Supattra
    Chokephaibulkit, Kulkanya
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (02) : E45 - E47
  • [49] Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study
    Schuller, E.
    Jilma, B.
    Voicu, V.
    Golor, G.
    Kollaritsch, H.
    Kaltenboeck, A.
    Klade, C.
    Tauber, E.
    VACCINE, 2008, 26 (34) : 4382 - 4386
  • [50] Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study
    Kaltenboeck, A.
    Dubischar-Kastner, K.
    Eder, G.
    Jilg, W.
    Klade, C.
    Kollaritsch, H.
    Paulke-Korinek, M.
    von Sonnenburg, F.
    Spruth, M.
    Tauber, E.
    Wiedermann, U.
    Schuller, E.
    VACCINE, 2009, 27 (33) : 4483 - 4489
12345